Patents Assigned to RheoGene, Inc.
  • Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
    Patent number: 9029152
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to novel substitution mutant receptors and their use in a Group H nuclear receptor-based inducible gene expression system and methods of modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: May 12, 2015
    Assignee: RheoGene, Inc.
    Inventors: Subba Reddy Palli, Mohan Basavaraju Kumar, Dean Ervin Cress, Ted Tsutomu Fujimoto
  • Ecdysone receptor-based inducible gene expression system
    Patent number: 7091038
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screetng assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: August 15, 2006
    Assignee: RheoGene, Inc.
    Inventors: Subba Reddy Palli, Marrianna Zinovjevna Kapitskaya, Dean Ervin Cress